Literature DB >> 9323273

Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications.

M Pagani1, S Stone-Elander, S A Larsson.   

Abstract

The increasing amount of clinically relevant information obtained by positron emission tomography (PET), primarily with fluorine-18 labelled 2-deoxy-2-fluoro-D-glucose, has generated a demand for new routes for the widespread and cost-efficient use of positron-emitting radiopharmaceuticals. New dual-head single-photon emission tomography (SPET) cameras are being developed which offer coincidence detection with camera heads lacking a collimator or SPET imaging with specially designed collimators and additional photon shielding. Thus, not only satellite PET imaging units but also nuclear medicine units investing in these new SPET/PET systems need to examine all available alternatives for rational radionuclide supplies from host cyclotrons. This article examines 25 "alternative" positron-emitting radionuclides, discusses the impact of their decay properties on image quality and reviews methods for their production as well as for their application in imaging techniques.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9323273     DOI: 10.1007/s002590050156

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  15 in total

Review 1.  PET tracers based on Zirconium-89.

Authors:  Yin Zhang; Hao Hong; Weibo Cai
Journal:  Curr Radiopharm       Date:  2011-04

Review 2.  Non-standard PET radionuclides: time to get ready for new clinical PET strategies.

Authors:  Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02       Impact factor: 9.236

Review 3.  Immuno-positron emission tomography in cancer models.

Authors:  Smitha Reddy; Matthew K Robinson
Journal:  Semin Nucl Med       Date:  2010-05       Impact factor: 4.446

4.  ImmunoPET using engineered antibody fragments: fluorine-18 labeled diabodies for same-day imaging.

Authors:  Tove Olafsen; Shannon J Sirk; Sebastian Olma; Clifton K-F Shen; Anna M Wu
Journal:  Tumour Biol       Date:  2012-03-06

Review 5.  Production of radiometals in liquid targets.

Authors:  Sergio J C do Carmo; Peter J H Scott; Francisco Alves
Journal:  EJNMMI Radiopharm Chem       Date:  2020-01-10

6.  Multivalent bifunctional chelator scaffolds for gallium-68 based positron emission tomography imaging probe design: signal amplification via multivalency.

Authors:  Ajay N Singh; Wei Liu; Guiyang Hao; Amit Kumar; Anjali Gupta; Orhan K Öz; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Bioconjug Chem       Date:  2011-07-26       Impact factor: 4.774

7.  B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma.

Authors:  Zhiping Zhou; Neal Luther; George M Ibrahim; Cynthia Hawkins; Rajeev Vibhakar; Michael H Handler; Mark M Souweidane
Journal:  J Neurooncol       Date:  2012-12-12       Impact factor: 4.130

Review 8.  Unconventional nuclides for radiopharmaceuticals.

Authors:  Jason P Holland; Matthew J Williamson; Jason S Lewis
Journal:  Mol Imaging       Date:  2010-02       Impact factor: 4.488

Review 9.  Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges.

Authors:  Tapan K Nayak; Martin W Brechbiel
Journal:  Bioconjug Chem       Date:  2009-05-20       Impact factor: 4.774

10.  Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86.

Authors:  Stéphan Walrand; François Jamar; Isabelle Mathieu; Joëlle De Camps; Max Lonneux; Mérence Sibomana; Daniel Labar; Christian Michel; Stanislas Pauwels
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-12-17       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.